MedPath
NMPA Approval

Levodopa and Benserazide Hydrochloride Tablets

国药准字H20254055

April 30, 2025

Drug Information

多巴丝肼片

片剂

左旋多巴0.2g与苄丝肼50mg(相当于盐酸苄丝肼57mg)

化学药品

April 30, 2025

Company Information

Applicant Company

广州市越秀区中山二路马棚岗22号6楼、7楼自编702

Manufacturing Company

浙江省绍兴市越城区袍江工业区三江路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多巴丝肼片 - NMPA 批准文号 | MedPath